Amphastar Financials

AMPH Stock  USD 44.55  0.46  1.04%   
Based on the analysis of Amphastar's profitability, liquidity, and operating efficiency, Amphastar P is performing exceptionally good at this time. It has a great probability to report excellent financial results in December. As of now, Amphastar's Total Current Liabilities is increasing as compared to previous years. The Amphastar's current Other Liabilities is estimated to increase to about 26.5 M, while Common Stock Shares Outstanding is projected to decrease to under 42.9 M. Key indicators impacting Amphastar's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.970.9282
Sufficiently Up
Slightly volatile
Current Ratio2.262.1721
Sufficiently Up
Very volatile
Investors should never underestimate Amphastar's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Amphastar's cash flow, debt, and profitability to make informed and accurate decisions about investing in Amphastar P.

Net Income

144.42 Million

  
Understanding current and past Amphastar Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Amphastar's financial statements are interrelated, with each one affecting the others. For example, an increase in Amphastar's assets may result in an increase in income on the income statement.

Amphastar Earnings Geography

Amphastar Stock Summary

Amphastar competes with Collegium Pharmaceutical, Alkermes Plc, Evolus, Neurocrine Biosciences, and Ironwood Pharmaceuticals. Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California. Amphastar Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 1761 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS03209R1032
CUSIP03209R103
LocationCalifornia; U.S.A
Business Address11570 6th Street,
SectorPharmaceuticals
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.amphastar.com
Phone909 980 9484
CurrencyUSD - US Dollar

Amphastar Key Financial Ratios

Amphastar Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets587.0M631.2M671.5M742.0M1.5B1.6B
Other Current Liab2.0M67.8M64.3M60.7M190.1M199.6M
Other Liab13.7M18.7M22.7M21.9M25.2M26.5M
Net Debt(7.1M)(25.4M)(21.7M)(53.5M)479.3M503.3M
Retained Earnings116.4M117.8M180.3M271.7M409.3M429.7M
Accounts Payable77.1M24.4M22.2M20.5M25.4M32.3M
Cash73.7M92.6M126.4M156.1M144.3M96.7M
Other Assets37.0M50.9M39.1M59.4M68.3M35.9M
Long Term Debt39.4M34.2M74.8M72.8M589.6M619.1M
Net Receivables45.7M66.0M78.8M88.8M114.9M58.4M
Good Will3.6M3.9M3.3M3.1M3.2M3.5M
Inventory110.5M96.8M92.8M103.6M105.8M91.3M
Other Current Assets9.5M11.2M9.8M17.7M21.1M22.1M
Total Liab159.4M182.5M226.0M213.3M873.5M917.2M
Total Current Assets255.2M279.7M318.1M378.3M489.6M277.4M
Short Term Debt10.9M19.0M8.2M9.1M8.2M9.9M
Intangible Assets37.5M36.7M35.6M34.2M610.1M640.6M
Net Tangible Assets340.2M361.7M406.7M491.4M565.1M361.3M
Long Term Debt Total39.4M34.2M74.8M72.8M83.8M48.0M
Capital Surpluse367.3M410.1M422.4M455.1M523.3M374.6M

Amphastar Key Income Statement Accounts

201920202021202220232024 (projected)
Interest Expense119K374K885K1.8M27.2M28.5M
Total Revenue322.4M349.8M437.8M499.0M644.4M343.3M
Gross Profit131.9M143.3M199.7M248.9M344.0M361.2M
Operating Income(39K)(14.2M)43.1M78.8M197.0M206.8M
Ebit(39K)5.0M85.0M78.8M199.7M209.7M
Research Development68.9M67.2M60.9M74.8M73.7M54.9M
Ebitda21.1M30.2M111.8M107.5M241.5M253.5M
Cost Of Revenue190.4M206.5M238.0M250.1M300.4M199.2M
Income Before Tax60.2M4.6M84.1M116.0M171.4M179.9M
Net Income48.9M1.1M62.1M91.4M137.5M144.4M
Income Tax Expense13.7M3.5M20.6M23.5M31.8M33.4M
Tax Provision13.7M3.5M20.6M23.5M34.5M36.2M
Interest Income997K642K601K1.3M3.7M3.9M
Net Interest Income878K268K(284K)(525K)(14.5M)(13.8M)

Amphastar Key Cash Accounts

201920202021202220232024 (projected)
Change To Inventory(41.1M)15.3M1.3M(11.7M)(1.7M)(1.8M)
Change In Cash(12.7M)19.0M32.1M29.7M(11.8M)(11.2M)
Free Cash Flow207K23.4M70.5M65.1M145.3M152.6M
Depreciation21.1M25.2M26.8M28.7M41.8M21.5M
Other Non Cash Items1.0M240K(13.0M)(878K)20.7M21.8M
Capital Expenditures41.6M33.9M27.5M24.0M38.2M30.4M
Net Income46.5M1.1M63.3M91.4M137.5M144.4M
End Period Cash Flow75.6M94.5M126.6M156.3M144.5M94.4M
Investments(8.8M)(1.1M)1.4M(7.8M)(546.3M)(519.0M)
Change Receivables6.7M(20.2M)(14.9M)(10.1M)(9.1M)(9.6M)
Net Borrowings(3.2M)(880K)30.4M(2.2M)(2.0M)(1.9M)
Change To Netincome22.9M20.6M8.0M2.7M3.1M3.0M

Amphastar Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Amphastar's current stock value. Our valuation model uses many indicators to compare Amphastar value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amphastar competition to find correlations between indicators driving Amphastar's intrinsic value. More Info.
Amphastar P is rated third in return on equity category among its peers. It is rated fifth in return on asset category among its peers reporting about  0.36  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Amphastar P is roughly  2.75 . As of now, Amphastar's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amphastar's earnings, one of the primary drivers of an investment's value.

Amphastar's Earnings Breakdown by Geography

Amphastar P Systematic Risk

Amphastar's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Amphastar volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Amphastar P correlated with the market. If Beta is less than 0 Amphastar generally moves in the opposite direction as compared to the market. If Amphastar Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Amphastar P is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Amphastar is generally in the same direction as the market. If Beta > 1 Amphastar moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Amphastar Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Amphastar's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Amphastar growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.44

As of now, Amphastar's Price Earnings To Growth Ratio is decreasing as compared to previous years.

Amphastar November 21, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Amphastar help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Amphastar P. We use our internally-developed statistical techniques to arrive at the intrinsic value of Amphastar P based on widely used predictive technical indicators. In general, we focus on analyzing Amphastar Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Amphastar's daily price indicators and compare them against related drivers.

Complementary Tools for Amphastar Stock analysis

When running Amphastar's price analysis, check to measure Amphastar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amphastar is operating at the current time. Most of Amphastar's value examination focuses on studying past and present price action to predict the probability of Amphastar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amphastar's price. Additionally, you may evaluate how the addition of Amphastar to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device